ClinicalTrials.gg
RecruitingNCT05629078Updated Mar 28, 2024

Vision and Balance Changes After Bilateral Implantation of Toric IOLs

An interventional study of Toric intraocular lens Zeiss AT TORBI in Cataract Bilateral and Astigmatism Bilateral, sponsored by University of Plymouth. Recruiting at 1 site in United Kingdom. Open to participants aged 50 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-03-28.

Sponsored by University of Plymouth · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
50 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 39 studies in Cataract with a site in United Kingdom — 8 open to participants now, 8 under way, 1 of them phase 3. Cataract · United Kingdom.

Planned enrollment
11th of 29
140 · median 100
Started
2024
with 1 other
No phase
23 of 39
4 open now
Registered
27th of 39
by date
Lead sponsor
4 of 39
University of Plymouth

Among the 39 studies in Cataract with a site in United Kingdom, this one is the 11th largest by planned enrollment of the 29 interventional ones that give a count, is one of 2 that started in 2024, is one of 23 with no phase, and was the 27th registered.

Cataract

1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.

Browse Cataract studies →

Open to participants now

8 of the 39 studies in Cataract with a site in United Kingdom are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.

This study: 50 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 39 studies in Cataract with a site in United Kingdom, or all of them as a file.
02

Study summary

Cataracts are the major cause of blindness in the world. Cataract surgery, being the most performed surgery in the world today, provide correction by extracting the natural lens from its capsular bag and replaced by an artificial intraocular lens (IOL) implantation. In the UK, almost all patients undergoing cataract surgery by the NHS are given monofocal intraocular lenses (IOLs) which do not correct corneal astigmatic error. It is estimated that around 20% of the population has over 1.50DC of corneal astigmatism. Uncorrected astigmatism not only increase spectacle dependency and reduce quality of life post surgically, but it also adversely affects the overall economic costs. Specialised toric IOLs offer the opportunity to correct pre-existing corneal astigmatism. Previous work has shown a link between reduced vision and balance or mobility. Full correction of refractive error may have greater impact on lifestyle than previously thought.

Read the detailed description

This is a single centre, parallel randomized controlled trial study comparing the dynamic stability and visual outcomes of cataract patient with astigmatism implanted with mono-focal Toric versus non-Toric IOLs.

140 cataracts patients with astigmatism awaiting cataract correction surgery at the Royal Eye infirmary of the University Hospitals of Plymouth NHS Trust will be recruited in this study over a two year period. The participants will be randomly assigned to be implanted with either Toric IOLs or standard non-Toric IOLs. Three additional study visits will be arranged for them. One visit before the cataract surgery, second visit at three to six months after the first eye cataract surgery and third visit at three to six months after the second eye cataract surgery. The primary assessment outcome is dynamic balance measured by movement sensors (accelerometer) during walk and turn, crossing over obstacle and stair walking. The secondary outcomes include eye tracking during movement activities, visual functions, risk of fall questionnaires and vision-specific quality of life questionnaire.

This project is funded by Carl Zeiss Meditec AG, led by the University of Plymouth and sponsored by University Hospitals Plymouth NHS Trust . The project also involves collaboration with the University of Glasgow and the Plymouth Marjon University.

03

Conditions studied

  • Cataract Bilateral
  • Astigmatism Bilateral

Browse trials for

Keywords

  • toric intraocular lens
  • dynamic stability
  • balance
  • post-cataract surgery
  • fear of falling
  • visual function
  • quality of life
04

Who can participate

Ages eligible
50 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • bilateral significant corneal astigmatism >1.0D
  • on waiting list for bilateral cataract surgery in NHS

Exclusion criteria

Exclusion Criteria:

  • pre-existing eye pathology which may be aggravated by intraocular implant
  • previous intraocular/ corneal surgery
  • History of uveitis, glaucoma, proliferative diabetic retinopathy or IDDM, pseudoexfoliation, macular degeneration that may affect potential best corrected visual acuity of 20/40 or better
  • Micropthalmia
  • corneal decompensation or endothelial insufficiency
  • pars planitis
  • high myopia
  • participants using a systematic medication that is known to cause ocular side effects
  • participated in a concurrent clinical trial or have participated in an opthalmology clinical trial within the last 30 days
  • unable or not willing to cooperate for the follow up period
  • pregnant women
  • unable to give
  • unable to walk with or without walking aids independently for at least 20m
  • unable to walk up/down stairs independently using aids or handrail
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
140 participants (estimated)

Study arms

  • Active comparator
    Toric Intraocular lens

    Toric intraocular lens- AT TORBI® 709M, to be implanted bilaterally in the cataract surgery to correct astigmatism at the same time.

    Device: Toric intraocular lens Zeiss AT TORBI

  • Active comparator
    Monofocal intraocular lens

    Standard monofocals IOLs- Zeiss CT ASPHINA 409/509M, to be implanted bilaterally in the standard NHS cataract surgery without correcting the astigmatism.

    Device: Toric intraocular lens Zeiss AT TORBI

Interventions

  • DeviceToric intraocular lens Zeiss AT TORBI

    Intraocular lenses are medical devices that are implanted in patients during cataract surgery. At Plymouth University NHS trust the standard lens is a monofocal non-Toric lens unless the patient has astigmatism greater than 4.00D. This study involves implantation of a toric lens in the intervention group where astigmatism is greater than 1.00D. The lens is called the toric IOLS- Zeiss AT TORBI, will be implanted bilaterally instead of standard monofocal IOLs- Zeiss CT ASPHINA, used in routine cataract surgery within NHS.

    Also known as: Monofocal non-toric intraocular lens Zeiss CT ASPHINA 409/509M

06

What researchers measure

Primary outcomes

  1. Jerk from the centre of mass Visit 1

    Assessed during functional activities using accelerometers

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  2. Jerk from the centre of mass Visit 2

    Assessed during functional activities using accelerometers

    Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery

  3. Jerk from the centre of mass Visit 3

    Assessed during functional activities using accelerometers

    Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

Secondary outcomes

  1. Unaided vision Visit 1

    Unaided vision measured on a LogMAR acuity chart

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  2. Unaided visionVisit 2

    Unaided vision measured on a LogMAR acuity chart

    Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery

  3. Unaided vision Visit 3

    Unaided vision measured on a LogMAR acuity chart

    Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  4. Visual acuity Visit 1

    Aided vision measured on a LogMAR acuity chart

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  5. Visual acuity Visit 2

    Aided vision measured on a LogMAR acuity chart

    Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery

  6. Visual acuity Visit 3

    Aided vision measured on a LogMAR acuity chart

    Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  7. Mean spherical refraction Visit 1

    Mean spherical refraction assessed through subjective refraction

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  8. Mean spherical refraction Visit 2

    Mean spherical refraction assessed through subjective refraction

    Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery

  9. Mean spherical refraction Visit 3

    Mean spherical refraction assessed through subjective refraction

    Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  10. Astigmatic power J0 Visit 1

    J0 assessed through subjective refraction and expressed in vector form

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  11. Astigmatic power J0 Visit 2

    J0 assessed through subjective refraction and expressed in vector form

    Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery

  12. Astigmatic power J0 Visit 3

    J0 assessed through subjective refraction and expressed in vector form

    Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  13. Astigmatic power J45 Visit 1

    J45 assessed through subjective refraction and expressed in vector form

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  14. Astigmatic power J45 Visit 2

    J45 assessed through subjective refraction and expressed in vector form

    Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery

  15. Astigmatic power J45 Visit 3

    J45 assessed through subjective refraction and expressed in vector form

    Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  16. Contrast sensitivity Visit 1

    Contrast sensitivity measured in log units

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  17. Contrast sensitivity Visit 2

    Contrast sensitivity measured in log units

    Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery

  18. Contrast sensitivity Visit 3

    Contrast sensitivity measured in log units

    Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  19. Rotation of IOL at visit 1

    Rotation of IOL relative to operation

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  20. Rotation of IOL at visit 2

    Rotation of IOL relative to operation

    Time frame: First assessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery

  21. Rotation of IOL at visit 3

    Rotation of IOL relative to Operation

    Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  22. Tilt of IOL at Visit 1

    Tilt of IOL assessed using image analysis

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  23. Tilt of IOL at Visit 2

    Tilt of IOL assessed using image analysis

    Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  24. Tilt of IOL at Visit 3

    Tilt of IOL assessed using image analysis

    Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  25. Centration of IOL at Visit 1

    Centration of IOL assessed using image analysis

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  26. Centration of IOL at Visit 2

    Centration of IOL assessed using image analysis

    Time frame: assessment at study visit 2 around 3-6 months after the first eye cataract IOL replacement surgery

  27. Centration of IOL at Visit 3

    Centration of IOL assessed using image analysis

    Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  28. Fear of falling

    Fear of falling measured using revised fear of falling questionnaire (FFR)

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  29. Fear of falling

    Fear of falling measured using revised fear of falling questionnaire (FFR)

    Time frame: assessment at study visit 2 around 3-6 months after the first eye cataract IOL replacement surgery

  30. Fear of falling

    Fear of falling measured using revised fear of falling questionnaire (FFR)

    Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  31. Risk of fall

    Risk of fall in daily activities measured by Short Fall Efficacy Scale Questionnaire (Short FFS-I)

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  32. Risk of fall

    Risk of fall in daily activities measured by Short Fall Efficacy Scale Questionnaire (Short FFS-I)

    Time frame: assessment at study visit 2 around 3-6 months after the first eye cataract IOL replacement surgery

  33. Risk of fall

    Risk of fall in daily activities measured by Short Fall Efficacy Scale Questionnaire (Short FFS-I)

    Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

  34. Cataract related quality of life

    Using Catract patient reported outcome measure CAT-PROM5 questionnaire

    Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery

  35. Cataract related quality of life

    Using Catract patient reported outcome measure CAT-PROM5 questionnaire

    Time frame: assessment at study visit 2 around 3-6 months after the first eye cataract IOL replacement surgery

  36. Cataract related quality of life

    Using Catract patient reported outcome measure CAT-PROM5 questionnaire

    Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery

07

Study locations

1 of 1 sites recruiting
  • Royal Eye Infirmary
    Plymouth, United Kingdom
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — no plan to share IPD

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Dec 2024, 11 months after the start.

Of 304 non-industry interventional studies with no phase under Cataract, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 11 months is below that.

Counting every sponsor, half of 494 studies reached it within 17 months; a quarter within 9 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 4, 2021
First posted
Nov 29, 2022
StartActual
Jan 12, 2024
Primary completionEst.
Dec 30, 2024
CompletionEst.
Jul 31, 2025
Last update
Mar 28, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05629078
Lead sponsor
University of Plymouth
Collaborators
Carl Zeiss Meditec AG, Glasgow Caledonian University, University of St Mark and St John Plymouth, University Hospital Plymouth NHS Trust
Responsible party
Dr Phillip J Buckhurst (Professor, University of Plymouth) — Principal investigator
First posted
Nov 29, 2022
Start date
Jan 12, 2024
Primary completion
Dec 30, 2024 (estimated)
Completion
Jul 31, 2025 (estimated)
Last update
Mar 28, 2024

Study contacts

Sherrie T Choy, MSc
Contact
sherrie.choy@plymouth.ac.uk
07903692005
Nabil Habib, MB ChB(Hons)
principal investigator · Royal Eye Infirmay, University Hosptials Plymouth NHS Trust
Phillip Buckhurst, PhD
study chair · University of Plymouth
Catriona MacLennan, PhD
study director · Glasgow Caledonian Unviersity
Gary L.K. Shum, PhD
study director · Plymouth Marjon University
Hetal Buckhurst, PhD
study director · University of Plymouth

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion